The Fort Worth Press - Flo Health Publishes Groundbreaking Research on Economic Impact of Digital Tools for Endometriosis Care

USD -
AED 3.67315
AFN 62.508602
ALL 82.901415
AMD 377.320103
ANG 1.790083
AOA 917.000446
ARS 1397.45603
AUD 1.43901
AWG 1.80225
AZN 1.700706
BAM 1.687977
BBD 2.01456
BDT 122.73608
BGN 1.709309
BHD 0.377588
BIF 2967.5
BMD 1
BND 1.279846
BOB 6.926967
BRL 5.284006
BSD 1.000203
BTN 93.723217
BWP 13.705842
BYN 2.961192
BYR 19600
BZD 2.011712
CAD 1.378275
CDF 2277.500338
CHF 0.791905
CLF 0.023254
CLP 918.179579
CNY 6.892698
CNH 6.90259
COP 3705.94
CRC 466.057627
CUC 1
CUP 26.5
CVE 95.375002
CZK 21.140432
DJF 177.720285
DKK 6.458295
DOP 59.874991
DZD 132.744974
EGP 52.575297
ERN 15
ETB 157.374952
EUR 0.864097
FJD 2.2267
FKP 0.74705
GBP 0.748095
GEL 2.714977
GGP 0.74705
GHS 10.905012
GIP 0.74705
GMD 73.000221
GNF 8780.00019
GTQ 7.659677
GYD 209.341164
HKD 7.82618
HNL 26.519884
HRK 6.514398
HTG 131.152069
HUF 338.600498
IDR 16919
ILS 3.12535
IMP 0.74705
INR 94.12285
IQD 1310
IRR 1315049.999853
ISK 124.289869
JEP 0.74705
JMD 157.845451
JOD 0.708962
JPY 159.145006
KES 129.505219
KGS 87.448496
KHR 4015.000082
KMF 425.000187
KPW 899.971148
KRW 1501.980286
KWD 0.30663
KYD 0.833571
KZT 482.866057
LAK 21550.000246
LBP 89549.999464
LKR 314.407654
LRD 183.602089
LSL 16.849649
LTL 2.95274
LVL 0.60489
LYD 6.395021
MAD 9.361979
MDL 17.4948
MGA 4164.999916
MKD 53.274154
MMK 2099.628947
MNT 3568.971376
MOP 8.061125
MRU 40.110041
MUR 49.241272
MVR 15.450211
MWK 1736.999739
MXN 17.821301
MYR 3.956501
MZN 63.899281
NAD 16.820108
NGN 1379.906022
NIO 36.720467
NOK 9.72285
NPR 149.95361
NZD 1.723707
OMR 0.384506
PAB 1.000203
PEN 3.473017
PGK 4.305501
PHP 60.074007
PKR 279.249903
PLN 3.69763
PYG 6526.476592
QAR 3.643996
RON 4.402503
RSD 101.500987
RUB 80.49933
RWF 1460
SAR 3.753711
SBD 8.051718
SCR 14.408321
SDG 600.99945
SEK 9.363065
SGD 1.280945
SHP 0.750259
SLE 24.550032
SLL 20969.510825
SOS 571.500489
SRD 37.340116
STD 20697.981008
STN 21.63
SVC 8.752314
SYP 110.977546
SZL 16.849782
THB 32.743003
TJS 9.597587
TMT 3.5
TND 2.904952
TOP 2.40776
TRY 44.34383
TTD 6.795811
TWD 31.96405
TZS 2569.999672
UAH 43.928935
UGX 3745.690083
UYU 40.762429
UZS 12205.000254
VES 456.504355
VND 26357
VUV 119.458227
WST 2.748874
XAF 566.134155
XAG 0.014408
XAU 0.000228
XCD 2.70255
XCG 1.802694
XDR 0.704159
XOF 568.499098
XPF 103.401522
YER 238.649518
ZAR 17.08035
ZMK 9001.198055
ZMW 18.929544
ZWL 321.999592
  • RBGPF

    -13.5000

    69

    -19.57%

  • RYCEF

    -0.4500

    15.6

    -2.88%

  • NGG

    0.4800

    82.54

    +0.58%

  • BCC

    1.9200

    73.8

    +2.6%

  • CMSC

    -0.1300

    22.75

    -0.57%

  • BCE

    0.1000

    25.86

    +0.39%

  • RIO

    0.7000

    86.54

    +0.81%

  • GSK

    1.0100

    53

    +1.91%

  • BTI

    0.1500

    58.07

    +0.26%

  • AZN

    1.8850

    185.955

    +1.01%

  • RELX

    -1.2250

    32.585

    -3.76%

  • VOD

    0.2100

    14.69

    +1.43%

  • JRI

    0.1800

    11.86

    +1.52%

  • CMSD

    -0.0800

    22.66

    -0.35%

  • BP

    1.0250

    44.595

    +2.3%

Flo Health Publishes Groundbreaking Research on Economic Impact of Digital Tools for Endometriosis Care
Flo Health Publishes Groundbreaking Research on Economic Impact of Digital Tools for Endometriosis Care

Flo Health Publishes Groundbreaking Research on Economic Impact of Digital Tools for Endometriosis Care

Peer-reviewed study finds Flo Health's Symptom Checker could deliver nearly $10,100 in net monetary benefit per patient while cutting diagnosis wait time in half

Text size:

NEW YORK CITY, NY / ACCESS Newswire / March 3, 2026 / Flo Health, the world's #1 women's health app, today announced publication of the first-ever economic evaluation of a digital symptom checker for endometriosis, underscoring the significant financial and health benefits that digital health technology can deliver to women navigating one of the most under-recognized conditions in gynecologic care.

The study, titled "Economic evaluation of a digital symptom checker for endometriosis using a Markov decision process model," and published in npj Digital Medicine, a top peer-reviewed journal in the Nature Portfolio, was conducted in partnership with researchers from The London School of Hygiene & Tropical Medicine and the York Health Economic Consortium. It examined the health and economic outcomes of using Flo Health's Symptom Checker alongside standard care, compared to standard care alone.

Despite affecting approximately 190 million women globally, endometriosis carries an average diagnostic delay of seven years, during which women frequently experience severe menstrual cramps, chronic pelvic pain, and pain during intercourse while receiving insufficient guidance. This delay is associated with increased disease severity, worsening pain, and more complex treatment paths.

The research produced the following key findings:

  • Women using Flo Health's Symptom Checker alongside standard care received diagnoses in approximately 3 years, compared to the 7-year average under standard care alone, a reduction of more than 50%

  • Patients gained nearly three weeks of additional healthy life, as measured by quality-adjusted life years (QALYs)

  • The tool generated approximately $5,196 USD in savings per person over 40 years through reduced medical costs and productivity gains

  • The total net monetary benefit per patient reached $10,089 USD, based on a willingness-to-pay threshold of $100,000 per QALY, a common benchmark for U.S. institutional payers

"When women are empowered to take control of their health, the benefits go beyond early diagnoses to overall improved physical and emotional well-being," said Dr. Anna Klepchukova, Chief Medical Officer at Flo Health. "This research explores how digital tools may help women better recognize their symptoms and bring clearer insights into conversations with their health care providers."

Flo Health's Symptom Checker is designed as an educational resource that helps users identify symptom patterns that may be consistent with endometriosis, prompting earlier engagement with health care providers. The tool is not intended to diagnose, treat, or replace professional medical care. More than 2.7 million women in the United States have used Flo Health's Symptom Tracker for endometriosis-related support.

Researchers also noted that digital symptom checkers provide the greatest value when tool accuracy exceeds 70%, user compliance surpasses 45%, and outcomes are measured over a minimum 10-year time horizon. The authors indicate that the economic modeling framework applied in this study could be replicated to evaluate digital health tools targeting other conditions that disproportionately affect women and face similar barriers to timely diagnosis.

The publication adds to a growing body of evidence supporting Flo Health's mission to build a better future for female health through trusted, data-backed digital tools. Flo Health currently supports 77 million monthly active users and collaborates with more than 100 medical experts worldwide.

About Flo Health

Flo Health is the leading app in the Health & Fitness category and the #1 OB-GYN-recommended app for period and cycle tracking. As the first European femtech unicorn following a General Atlantic investment in July 2024, Flo Health supports 77 million monthly active users with curated cycle and ovulation tracking, tailored health insights, and a private community for women at every stage of life. Through its Pass it on Project, Flo Health has donated 20 million Premium subscriptions toward its goal of providing 1 billion women in need with free access to health information. For more information, visit flo.health.

PR Contact
Samantha Wannemacher
Flo Health
[email protected]

SOURCE: Flo Health



View the original press release on ACCESS Newswire

G.George--TFWP